Total Funding
61
82
Total FundingDebt Financing raised
Growth Score
-29 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39982
Avotres is a biotechnology company that provides therapeutic solutions for immunologically mediated disorders.
- Hong Jiang: Founder & Chief Scientific Officer (CSO)
- John C. Houghton: President & CEOPast Role: Nephros, President & CEO
About the Company
Avotres is a biotechnology company that is developing novel therapeutics for incurable immunologically mediated diseases. In these therapeutic areas with significant unmet medical needs, they use cutting-edge science to uncover potentially paradigm-shifting immunological pathways in they improving the lives of millions of patients. AVT002, a
monoclonal antibody, is also being developed as a potential cancer therapy directed at a novel immuno-oncology target.
Women Founded
